@article{TRO4975,
author = {Andrea Riccardo Filippi and Andrea Lancia and Marco Trovo},
title = {Stereotactic radiotherapy in previously treated lung cancers—what are the risks?},
journal = {Therapeutic Radiology and Oncology},
volume = {3},
number = {0},
year = {2019},
keywords = {},
abstract = {Patients affected by intra-thoracic recurrences of primary or secondary lung malignancies after the first course of definitive radiotherapy (RT) have limited therapeutic options, and they are often treated with palliative intent. Re-irradiation with stereotactic radiotherapy (SRT) represents an appealing approach, due to the optimized dose distribution that allows for high-dose delivery with better sparing of organs at risk; however, toxicity still represents an issue, even with dose-fractionation risk-adapted approaches. This review aims to analyze clinical data and dosimetric parameters related to stereotactic re-irradiation, mainly focusing on the toxicity profile, whose risk often limits the adoption of this technique in clinical practice.},
issn = {2616-2768}, url = {https://tro.amegroups.org/article/view/4975}
}